Goike, Jule
Hsieh, Ching-Lin http://orcid.org/0000-0002-3665-5717
Horton, Andrew P. http://orcid.org/0000-0002-0272-4411
Gardner, Elizabeth C.
Zhou, Ling
Bartzoka, Foteini
Wang, Nianshuang
Javanmardi, Kamyab
Herbert, Andrew
Abbassi, Shawn
Xie, Xuping http://orcid.org/0000-0003-0918-016X
Xia, Hongjie http://orcid.org/0000-0002-2520-7038
Shi, Pei-Yong http://orcid.org/0000-0001-5553-1616
Renberg, Rebecca http://orcid.org/0000-0003-0640-5087
Segall-Shapiro, Thomas H.
Terrace, Cynthia I.
Wu, Wesley
Shroff, Raghav
Byrom, Michelle
Ellington, Andrew D. http://orcid.org/0000-0001-6246-5338
Marcotte, Edward M. http://orcid.org/0000-0001-8808-180X
Musser, James M.
Kuchipudi, Suresh V. http://orcid.org/0000-0002-8640-254X
Kapur, Vivek
Georgiou, George http://orcid.org/0000-0002-8823-3073
Weaver, Scott C. http://orcid.org/0000-0001-8016-8556
Dye, John M.
Boutz, Daniel R. http://orcid.org/0000-0001-7462-4105
McLellan, Jason S. http://orcid.org/0000-0003-3991-542X
Gollihar, Jimmy D. http://orcid.org/0000-0003-3957-2092
Article History
Received: 19 April 2023
Accepted: 29 November 2023
First Online: 11 December 2023
Competing interests
: ADE, EMM, GG, and DRB declare competing financial interests in the form of provisional and granted patent applications relevant to IgSeq. JG, CH, ECG, APH, DRB, EMM, JSM, ADE, GG, and JDG have filed provisional applications for the discovery of neutralizing antibodies. JG, DRB, ECG, APH, and JDG have filed applications for additional methods relevant to this work. All other authors declare no competing interests.
: The acquisition of blood specimens from convalescent individuals was approved by the University of Texas at Austin Institutional Review Board (protocol 2020-03-085; Breadth of serum antibody immune responses prior to, or following, patient recovery in asymptomatic and non-severe COVID-19). Informed consent was obtained from all participants. All ethical regulations relevant to human research participants were followed.